Capstan Therapeutics logo

Capstan Therapeutics, Inc.

Biotechnology

Capstan Therapeutics Stock

Capstan Therapeutics is developing in vivo RNA-based therapies for oncology, fibrosis, and inflammation-related diseases. Its platform utilizes targeted lipid nanoparticles for precise delivery and control of engineered cells, aiming to advance innovative treatments in these fields.

Management Team

Laura Shawver Ph.D. President & Chief Executive Officer
Justin Thacker Chief Financial Officer
Priya Karmali Ph.D. Chief Technology Officer
Adrian Bot Ph.D. Founding Chief Scientific Officer, Executive Vice President of Research & Development
Haig Aghajanian Ph.D. Co-Founder & Vice President of Research
Ramin Farzaneh-Far MD Chief Medical Officer

Funding Information